Yokokura H, Picciotto M R, Nairn A C, Hidaka H
Department of Pharmacology, Nagoya University School of Medicine, Japan.
J Biol Chem. 1995 Oct 6;270(40):23851-9. doi: 10.1074/jbc.270.40.23851.
The mechanism for the regulation of Ca2+/calmodulin-dependent protein kinase I (CaM kinase I) was investigated using a series of COOH-terminal truncated mutants. These mutants were expressed in bacteria as fusion proteins with glutathione S-transferase and purified by affinity chromatography using glutathione Sepharose 4B. A mutant (residues 1-332) showed complete Ca2+/CaM-dependent activity. Truncation mutants (residues 1-321, 1-314, and 1-309) exhibited decreasing affinities for Ca2+/CaM and also exhibited decreasing Ca2+/CaM-dependent activities. Truncation mutants (residues 1-305 or 1-299) were unable to bind Ca2+/CaM and were inactive. In contrast, truncation mutants (residues 1-293 or 1-277) were constitutively active at a slightly higher level (2-fold) than fully active CaM kinase I. These results indicate the location of the Ca2+/CaM-binding domain on CaM kinase I (residues 294-321) and predict the existence of an autoinhibitory domain near, or overlapping, the Ca2+/CaM-binding domain. These conclusions were supported by studies which showed that a synthetic peptide (CaM kinase I (294-321)) corresponding to residues 294-321 of CaM kinase I inhibited the fully active kinase in a manner that was competitive with Ca2+/CaM and also inhibited the constitutively active mutant (residues 1-293) in a manner that was competitive with Syntide-2, a peptide substrate, (Ki = 1.2 microM) but was non-competitive with ATP. Thus, these results suggest that CaM kinase I is regulated through an intrasteric mechanism common to other members of the family of Ca2+/CaM-dependent protein kinases.
利用一系列羧基末端截短突变体对钙调蛋白依赖性蛋白激酶I(CaM激酶I)的调节机制进行了研究。这些突变体在细菌中作为与谷胱甘肽S-转移酶的融合蛋白表达,并使用谷胱甘肽琼脂糖4B通过亲和色谱法纯化。一个突变体(第1-332位氨基酸残基)表现出完全的钙/钙调蛋白依赖性活性。截短突变体(第1-321、1-314和1-309位氨基酸残基)对钙/钙调蛋白的亲和力降低,并且钙/钙调蛋白依赖性活性也降低。截短突变体(第1-305或1-299位氨基酸残基)无法结合钙/钙调蛋白且无活性。相反,截短突变体(第1-293或1-277位氨基酸残基)比完全活性的CaM激酶I具有略高(2倍)的组成型活性。这些结果表明了CaM激酶I上钙/钙调蛋白结合结构域的位置(第294-321位氨基酸残基),并预测在钙/钙调蛋白结合结构域附近或与之重叠存在一个自抑制结构域。这些结论得到了研究的支持,这些研究表明,与CaM激酶I的第294-321位氨基酸残基相对应的合成肽(CaM激酶I(294-321))以与钙/钙调蛋白竞争的方式抑制完全活性的激酶,并且以与肽底物Syntide-2竞争的方式(Ki = 1.2 microM)抑制组成型活性突变体(第1-293位氨基酸残基),但与ATP无竞争性。因此,这些结果表明CaM激酶I是通过一种与钙/钙调蛋白依赖性蛋白激酶家族其他成员共有的分子内机制进行调节的。